Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Barnes

Showing results (251-260 of 285) with videos related to

Pageof 29
Sort By:
Cancer Research|March 15, 1989
1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linkingL J Swinnen, D M Barnes, S G Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
BAG-1 immunostaining and survival in early breast cancerR I Cutress, P A Townsend, A C Bateman, et al.
British Journal of Cancer|March 1, 1991
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesW J Gullick, S B Love, C Wright, et al.
Endocrine-Related Cancer|March 19, 2004
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patientsD M Barnes, R R Millis, C E Gillett, et al.
British Journal of Cancer|May 1, 1987
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breastA D Baildam, J Zaloudik, A Howell, et al.
The Journal of Pathology|July 9, 1999
p21(WAF1) expression and endocrine response in breast cancerR A McClelland, J M Gee, L O'Sullivan, et al.
British Journal of Cancer|May 1, 1990
DNA index, S-phase fraction, histological grade and prognosis in breast cancerS M O'Reilly, R S Camplejohn, D M Barnes, et al.
International Journal of Cancer|April 3, 1999
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenograftsS Detre, J Salter, D M Barnes, et al.
Cancer Research|January 1, 1987
Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatmentA Howell, R N Harland, D M Barnes, et al.
International Journal of Cancer|September 27, 2000
Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancerA M Hanby, D P Kelsell, H W Potts, et al.
Pageof 29

Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
Cancer Research|March 15, 1989
1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linkingL J Swinnen, D M Barnes, S G Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
BAG-1 immunostaining and survival in early breast cancerR I Cutress, P A Townsend, A C Bateman, et al.
British Journal of Cancer|March 1, 1991
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodesW J Gullick, S B Love, C Wright, et al.
Endocrine-Related Cancer|March 19, 2004
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patientsD M Barnes, R R Millis, C E Gillett, et al.
British Journal of Cancer|May 1, 1987
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breastA D Baildam, J Zaloudik, A Howell, et al.
The Journal of Pathology|July 9, 1999
p21(WAF1) expression and endocrine response in breast cancerR A McClelland, J M Gee, L O'Sullivan, et al.
British Journal of Cancer|May 1, 1990
DNA index, S-phase fraction, histological grade and prognosis in breast cancerS M O'Reilly, R S Camplejohn, D M Barnes, et al.
International Journal of Cancer|April 3, 1999
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenograftsS Detre, J Salter, D M Barnes, et al.
Cancer Research|January 1, 1987
Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatmentA Howell, R N Harland, D M Barnes, et al.
International Journal of Cancer|September 27, 2000
Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancerA M Hanby, D P Kelsell, H W Potts, et al.
Pageof 29